Fumihiro Yanagimura1,5, Akihiro Nakajima1, Etsuji Saji1, Takashi Nakajima5, Hiroshi Shimizu2, Yasuko Toyoshima2,8, Akiyoshi Kakita2, Hitoshi Takahashi6,7, Masatoyo Nishizawa4,7, Osamu Onodera1, Izumi Kawachi1,3 (1.Department of Neurology, Brain Research Institute, Niigata University, Japan, 2.Department of Pathology, Brain Research Institute, Niigata University, Japan, 3.Comprehensive Medical Education Center, Niigata University School of Medicine, Japan, 4.Niigata University of Health and Welfare, Japan, 5.Department of Neurology, NHO Niigata National Hospital, Japan, 6.Niigata Neurosurgical Hospital, Japan, 7.Brain Research Institute, Niigata University, Japan, 8.Agano Hospital, Japan)
Session information
Oral Session
English
[O-41] Oral Session 41 [English]「Neuroimmunology 5」
Sat. Jun 1, 2024 8:00 AM - 9:30 AM Room4 (Hall B5 (1), B Block, 5F, TIF)
Chair(s): Yuji Nakatsuji (Department of Neurology, Faculty of Medicine, University of Toyama, Japan), Yuko Shimizu (Dep. of Medical Safety and Dep. of Neurology Tokyo Women's Medical University, Japan)
Takayuki Fujii, Yuka Inoue, Mitsuru Watanabe, Katsuhisa Masaki, Noriko Isobe (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan)
Kimihiko Kaneko1, Hiroshi Kuroda1,2,3, Yuki Matsumoto1,2,4, Naohiro Sakamoto1, Shu Umezawa1, Naoki Yamamoto1, Naoya Yamazaki1, Chihiro Namatame1, Hirohiko Ono1, Yoshiki Takai1, Toshiyuki Takahashi1,5, Juichi Fujimori6, Ichiro Nakashima6, Yasuo Harigaya7, Kazuo Fujihara1,2,3, Tatsuro Misu1, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Southern TOHOKU Research Institute for Neuroscience Southern TOHOKU General Hospital, Japan, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 4.Department of Neurology, NHO Miyagi National Hospital, Japan, 5.Department of Neurology, NHO Yonezawa National Hospital, Japan, 6.Department of Neurology, Tohoku Medical and Pharmaceutical University, Japan, 7.Department of Neurology, Japanese Redcross Maebashi Hospital, Japan)
Jun-ichi Kira1,2,3, Maimaitijiang Guzailiayi2, Ayako Sakoda1,2, Mitsuru Watanabe4, Satoshi Nagata4, Ozdemir Ezgi4, Katsuhisa Masaki4, Ryo Yamasaki4, Noriko Isobe4, Xu Zhang2, Tomohiro Imamura2,3, Yuri Nakamura1,2,3 (1.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Japan, 2.Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Japan, 3.School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 4.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan)
Cossu Davide1,2, Yuji Tomizawa1, Sechi Leonardo A.2, Nobutaka Hattori1 (1.Juntendo University, Japan, 2.Sassari University, Italy)
Siwakorn Chaiyanarm1, Piraya Satiraphan1, Natnasak Apiraksattayakul2, Jiraporn Jitprapaikulsan2,3, Weerapat Owattanapanich4, Tarinee Rungjirajittranon4, Witsarut Nanthasi3 (1.Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, 2.Siriraj Neuroimmunology Center, Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, 3.Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, 4.Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand)